STLN

Conviction 0HealthcareScan · Fri, Oct 2, 2026

Starling Oncology, Inc. (STLN) closed at $6.37 (+2.49%) on Oct 2, 2026. RSI(14) 51, -9.7% from its 52-week high, +23.2% year to date. Sector: Healthcare.

STLN$6.37+2.49%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.44M

Aug 4Aug 14Aug 27Sep 9Sep 22Oct 2

Starling Oncology, Inc.

Price6.37

Change+2.49%

Gap+1.45%

Rel volume0.41×

Avg volume1.31M

Avg $ vol8.64M

SMA 206.49

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 5.76

RSI (14)51

MACD hist-0.07

MACD crossbear · 4d

Stoch %K / %D20 / 17

ADX (14)35

+DI / −DI17 / 14

RSI divergence—

MACD divergence—

ATR %5.82%

ADR %5.64%

52w high7.05

52w low4.99

From 52w high-9.65%

Above 52w low+27.66%

New 52w highNo

SqueezeOff

Bollinger width17.07%

%B0.39

Donchian pos40.63%

Donchian high7.13

Donchian low5.85

AVWAP (52w high)6.70

vs AVWAP high-4.95%

AVWAP (52w low)6.40

vs AVWAP low-0.42%

OBV trendFlat

Chaikin MF (20)-0.06

Today vs 20d0.41×

Avg vol (14d)1.44M

Avg vol (20d)1.31M

Avg $ vol (20d)8.64M

Market cap649.21M

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank73.0

1 week-4.35%

1 month+4.60%

3 months—

6 months—

1 year—

YTD+23.21%

P/E-10.71

P/B-26.06

P/S1.29

P/FCF-23.36

EPS-0.5400

Div yield—

ROE243.26%

ROA-34.00%

Debt/Eq-3.21

Current1.36

EV/EBITDA-25.01

Gross margin—

Net margin-12.06%

Rev growth27.79%

EPS growth6.27%

Price target9.25

Target upside45.21%

Analyst ratingBuy

Institutional44.85%

Ent. value728.87M

Revenue161.28M

Net income-9.79M

Gross profit—

Free cash flow-27.79M

Industry—

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float21.54M

Float %21.1%

Short interest6.82M

Days to cover5.6d

Short volume39.7%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.08 vs −$0.07

Last surprise-14.3% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank73.0 / 100

Group rank14 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.97

Support5.79

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in STLN

All disclosures →

No recent disclosed trades by Congress in STLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STLN · open-market 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Hively Brad Director · Common Stock · 2026-08-21	Sell	298.85K	$1.9M	2026-08-21	2026-08-24
Chernett Jorey 10% owner · Common Stock · 2026-08-14	Buy	12K	$78K	2026-08-14	2026-08-17
Chernett Jorey 10% owner · Call Option (STLN 19FEB27 $9C) · 2026-08-13	Sell	100	$624	2026-08-13	2026-08-17

SEC filings

EDGAR filings in STLN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.